Rucaparib – 10 mg

Brand:
Cayman
CAS:
283173-50-2
Storage:
-20
UN-No:
Non-Hazardous - /

Poly(ADP-ribose) polymerases (PARPs) are activated by DNA single- and double-strand breaks and promote repair of DNA damage through the relaxation of chromatin and recruitment of other repair proteins.{20554,20553,20549} Inhibition of PARP activity has been linked to synthetic lethality in cells with mutations in BRCA1 or BRCA2 and is used as a therapeutic strategy to selectively target cancers.{20680,20677} Rucaparib is a potent, cell-permeable inhibitor of PARP1 (Ki = 50 values ranging from 1.3-5.5 μM.{20679} At 25 mg/kg, rucaparib arrests tumor growth in mice bearing epigenetically silenced BRCA1 UACC3199 xenograft tumors.{20679} It has been shown to increase efficacy of temozolomide in medulloblastoma cells and xenografts.{20678}  

 

SKU: - Category:

Description

A potent, cell-permeable inhibitor of PARP1 (Ki = 50s = 1.3-5.5 μM); arrests tumor growth in mice bearing epigenetically silenced BRCA1 UACC3199 xenograft tumors


Formal name: 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one

Synonyms:  AG-014447

Molecular weight: 323.4

CAS: 283173-50-2

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|DNA Repair Enzymes||Research Area|Cancer|DNA Damage and Repair|PARP